Loading
Nutrition screening means weighing every patient, asking a few screening questions, and referring those at risk to a dietitian. It is simple, guideline-endorsed, and still not done routinely.
Malnutrition affects 20-70% of cancer patients depending on site and stage and independently predicts treatment toxicity, complications, hospital stay and death. ESPEN (2017, 2021) and ASCO (2020) recommend screening all patients at diagnosis and at intervals with a validated tool (MUST, NRS-2002, MST or PG-SGA), followed by assessment of intake, body composition, inflammation and function, and stepwise medical nutrition therapy: dietary counselling, oral nutritional supplements, then artificial nutrition when oral intake fails. Randomised evidence is strongest for dietitian counselling in head and neck and gastrointestinal cancers, where it improves intake, weight and treatment completion. The EFFORT trial in general medical inpatients (Lancet 2019) showed individualised nutrition support reduced mortality, with a cancer subgroup consistent with the overall effect.
Screen early, before weight loss becomes irreversible; treat the reversible causes (nutrition impact symptoms, inflammation, inactivity) and match support to the patient's prognosis and goals.
Three technology pages and two term pages on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
One technology page and one bottleneck page on OnCo cite this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing pages listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
One technology page on OnCo cites this paper by its DOI; this record gives the citation a page of its own so a reader can follow it without leaving OnCo. Read the abstract above alongside the citing page listed under Related; the record was created automatically from the Europe PMC entry and its figures have not been checked by hand.
Query for this technology: (TITLE:"Oncology nutrition assessment and medical nutrition therapy" OR ABSTRACT:"Oncology nutrition assessment and medical nutrition therapy") AND (cancer OR tumor OR tumour OR oncology OR carcinoma OR lymphoma OR leukemia OR leukaemia OR myeloma OR sarcoma OR melanoma OR glioma). Results are unfiltered search hits about Oncology nutrition assessment and medical nutrition therapy, not a curated reading list.
Shares ESPEN practical guideline: Clinical Nutrition in cancer, Fish oil (EPA) for cancer weight loss, Body composition (lean mass, fat mass, visceral fat), Muscle and strength after treatment: sarcopenia, cachexia and what rebuilds.
Shares Body composition (lean mass, fat mass, visceral fat), Muscle and strength after treatment: sarcopenia, cachexia and what rebuilds, CT body composition and sarcopenia measurement, Sarcopenia.
Shares Nutrition impact symptoms, Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), Nutrition support and cachexia management, Cachexia, toxicity and the limits of the patient.
Shares Body composition (lean mass, fat mass, visceral fat), CT body composition and sarcopenia measurement, Sarcopenia, Cancer cachexia.
Shares A dietitian in every gastrointestinal and head and neck tumour board, Malnutrition screening tools (MUST, NRS-2002, MST, PG-SGA), CT body composition and sarcopenia measurement, Nutrition support and cachexia management.
Shares Fish oil (EPA) for cancer weight loss, Muscle and strength after treatment: sarcopenia, cachexia and what rebuilds, Cancer cachexia, Geriatric assessment.
Shares Body composition (lean mass, fat mass, visceral fat), Muscle and strength after treatment: sarcopenia, cachexia and what rebuilds, Sarcopenia, Cachexia, toxicity and the limits of the patient.
Shares Pancreatic enzyme replacement therapy (PERT, pancreatin, Creon) for pancreatic exocrine insufficiency: why and how to take it, Nutrition impact symptoms, Nutrition support and cachexia management, Pancreatic ductal adenocarcinoma.